(Q36677016)

15 August 2017

1 reference

title

The curiously suspicious: a role for Epstein-Barr virus in lupus (English)

1 reference

15 August 2017

0 references

3

J M Guthridge

1 reference

15 August 2017

1

J B Harley

1 reference

15 August 2017

4

J A James

1 reference

15 August 2017

I T W Harley

2

1 reference

15 August 2017

1 January 2006

1 reference

15 August 2017

1 reference

15 August 2017

15

1 reference

15 August 2017

11

1 reference

15 August 2017

768-777

1 reference

The emerging role of interferon in human systemic lupus erythematosus

15 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F0961203306070009

Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306070009

Interferon-alpha in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306070009

Susceptibility genes in the pathogenesis of murine lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306070009

Genetic basis of murine lupus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306070009

Genetics of systemic lupus erythematosus: how far have we come?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306070009

A revised estimate of twin concordance in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306070009

Kawasaki syndrome clusters in Harris County, Texas, and eastern North Carolina. A high endemic rate and a new environmental risk factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306070009

The elusive search for geographic clusters of systemic lupus erythematosus. Critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306070009

Fine specificity of the autoimmune response to the Ro/SSA and La/SSB ribonucleoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306070009

Epitope mapping of the 52-kD Ro/SSA autoantigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306070009

Antibodies to vesicular stomatitis virus proteins in patients with systemic lupus erythematosus and in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306070009

The leader RNA of vesicular stomatitis virus is bound by a cellular protein reactive with anti-La lupus antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306070009

Antibodies to EYRKK vesicular stomatitis virus-related peptide account only for a minority of anti-Ro60kD antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306070009

Immunoglobulin epitope spreading and autoimmune disease after peptide immunization: Sm B/B'-derived PPPGMRPP and PPPGIRGP induce spliceosome autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306070009

Shared early autoantibody recognition events in the development of anti-Sm B/B' in human lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306070009

Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306070009

An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306070009

Epstein-Barr virus infection may be an environmental risk factor for systemic lupus erythematosus in children and teenagers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306070009

Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306070009

Epstein-Barr virus and molecular mimicry in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306070009

Epstein-Barr virus and systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306070009

Detecting Epstein-Barr virus DNA from peripheral blood mononuclear cells in adult patients with systemic lupus erythematosus in Taiwan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306070009

Patients with systemic lupus erythematosus have abnormally elevated Epstein-Barr virus load in blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306070009

Defective control of latent Epstein-Barr virus infection in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306070009

EBV and systemic lupus erythematosus: a new perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306070009

Phenotypic and functional analysis of EBV-specific memory CD8 cells in SLE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306070009

Epstein-Barr virus and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306070009

Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306070009

Differential immunogenicity of Epstein-Barr virus latent-cycle proteins for human CD4(+) T-helper 1 responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306070009

CD4+ T cell responses in the immune control against latent infection by Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306070009

Presentation of epstein-barr virus latency antigens to CD8(+), interferon-gamma-secreting, T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306070009

An altered immune response to Epstein-Barr nuclear antigen 1 in pediatric systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306070009

Systemic lupus erythematosus associated with acute Epstein-Barr virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306070009

Systemic lupus erythematosus induced by Epstein-Barr virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306070009

Systemic lupus erythematosus due to Epstein-Barr virus or Epstein-Barr virus infection provocating acute exacerbation of systemic lupus erythematosus?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306070009

Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306070009

CD40 and its viral mimic, LMP1: similar means to different ends

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306070009

Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306070009

The effects of the Epstein-Barr virus latent membrane protein 2A on B cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306070009

Epstein-Barr virus-induced autoimmune responses. I. Immunoglobulin M autoantibodies to proteins mimicking and not mimicking Epstein-Barr virus nuclear antigen-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306070009

Epstein-Barr virus-induced autoimmune responses. II. Immunoglobulin G autoantibodies to mimicking and nonmimicking epitopes. Presence in autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306070009

The latent membrane protein 1 of Epstein-Barr virus (EBV) primes EBV latency cells for type I interferon production

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306070009

Compartmentalization and transmission of multiple epstein-barr virus strains in asymptomatic carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306070009

21 January 2018

Identifiers

DOI

10.1177/0961203306070009

1 reference

15 August 2017

1 reference

PubMed ID

17153849